Open conformers: the hidden face of MHC-I molecules

Trends in Immunology

Volumn 28, Issue 3, 2007, Pages 115-123

  Arosa, Fernando A ^a   Santos, Susana G ^b   Powis, Simon J ^b  

^a UNIVERSITY OF PORTO   (Portugal)

^b UNIVERSITY OF ST ANDREWS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LIGAND; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; NATURAL KILLER CELL RECEPTOR;

AMINO ACID SEQUENCE; CELL MEMBRANE; HEAVY CHAIN; HUMAN; INNATE IMMUNITY; LIGAND BINDING; LIGHT CHAIN; MAJOR HISTOCOMPATIBILITY COMPLEX; MOLECULAR INTERACTION; NATURAL KILLER T CELL; NONHUMAN; PROTEIN FUNCTION; REVIEW; T LYMPHOCYTE;

ANIMALS; DIMERIZATION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; PROTEIN CONFORMATION;

EID: 33847155383     PISSN: 14714906     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.it.2007.01.002     Document Type: Review

References (98)

1. Antoniou A.N., et al. Assembly and export of MHC class I peptide ligands. Curr. Opin. Immunol. 15 (2003) 75-81
2. Hughes E.A., et al. Misfolded major histocompatibility complex class heavy chains are translocated into the cytoplasm and degraded by the proteasome. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 1896-1901
3. Tirosh B., et al. Human cytomegalovirus protein US11 provokes an unfolded protein response that may facilitate the degradation of class I major histocompatibility complex products. J. Virol. 79 (2005) 2768-2779
4. Cresswell P., et al. Mechanisms of MHC class I-restricted antigen processing and cross-presentation. Immunol. Rev. 207 (2005) 145-157
5. Vivier E., and Anfossi N. Inhibitory NK-cell receptors on T cells: witness of the past, actors of the future. Nat. Rev. Immunol. 4 (2004) 190-198
6. 2-microglobulin. J. Exp. Med. 171 (1990) 1431-1442
7. Madrigal J.A., et al. Molecular definition of a polymorphic antigen (LA45) of free HLA-A and -B heavy chains found on the surfaces of activated B and T cells. J. Exp. Med. 174 (1991) 1085-1095
8. Grassi F., et al. Human immunodeficiency virus type 1 gp120 mimics a hidden monomorphic epitope borne by class I major histocompatibility complex heavy chains. J. Exp. Med. 174 (1991) 53-62
9. 2m-free MHC class I molecules induced on activated T cells. Cell. Immunol. 142 (1992) 103-113
10. Sernee M.F., et al. Why certain antibodies cross-react with HLA-A and HLA-G: epitope mapping of two common MHC class I reagents. Mol. Immunol. 35 (1998) 177-188
11. Arosa F.A., et al. Calreticulin is expressed on the cell surface of activated human peripheral blood T lymphocytes in association with major histocompatibility complex class I molecules. J. Biol. Chem. 274 (1999) 16917-16922
12. 2-Microglobulin-free HLA class I heavy chain epitope mimicry by monoclonal antibody HC-10-specific peptide. J. Immunol. 171 (2003) 1918-1926
13. Santos S.G., et al. Misfolding of major histocompatibility complex class I molecules in activated T cells allows cis-interactions with receptors and signaling molecules and is associated with tyrosine phosphorylation. J. Biol. Chem. 279 (2004) 53062-53070
14. Hansen T.H., et al. Recognition of open conformers of classical MHC by chaperones and monoclonal antibodies. Immunol. Rev. 207 (2005) 100-111
15. Stefani M. Protein misfolding and aggregation: new examples in medicine and biology of the dark side of the protein world. Biochim. Biophys. Acta 1739 (2004) 5-25
16. Fehlmann M., et al. Molecular association between major histocompatibility complex class I antigens and insulin receptors in mouse liver membranes. Proc. Natl. Acad. Sci. U. S. A. 82 (1985) 8634-8637
17. Phillips M.L., et al. Class I histocompatibility antigens and insulin receptors: evidence for interactions. Proc. Natl. Acad. Sci. U. S. A. 83 (1986) 3474-3478
18. Due C., et al. The major histocompatibility complex class I heavy chain as a structural subunit of the human cell membrane insulin receptor: implications for the range of biological functions of histocompatibility antigens. Proc. Natl. Acad. Sci. U. S. A. 83 (1986) 6007-6011
19. Samson M., et al. Cross-linking of insulin receptors to MHC antigens in human B lymphocytes: evidence for selective molecular interactions. J. Immunol. 137 (1986) 2293-2298
20. Schreiber A.B., et al. Interaction between major histocompatibility complex antigens and epidermal growth factor receptors on human cells. J. Cell Biol. 98 (1984) 725-731
21. Sharon M., et al. Possible association between IL-2 receptors and class I HLA molecules on T cells. J. Immunol. 141 (1988) 3512-3515
22. Harel-Bellan A., et al. Flow cytometry resonance energy transfer suggests an association between low-affinity interleukin 2 binding sites and HLA class I molecules. Biochem. J. 268 (1990) 35-40
23. Simonsen M., et al. Compound receptors in the cell membrane: ruminations from the borderland of immunology and physiology. Prog. Allergy 36 (1985) 151-176
24. Edidin M. Function by association? MHC antigens and membrane receptor complexes. Immunol. Today 9 (1988) 218-219
25. Ramalingam T.S., et al. Interaction of class I human leukocyte antigen (HLA-I) molecules with insulin receptors and its effect on the insulin-signaling cascade. Mol. Biol. Cell 8 (1997) 2463-2474
26. Arosa F.A., et al. The impact of environmental signals in the growth and survival of human T cells. In: Damjanovich S. (Ed). Biophysical Aspects of Transmembrane Signaling Vol. 8 (2005), Springer Verlag 1-32
27. Blue M.L., et al. Evidence for specific association between class I major histocompatibility antigens and the CD8 molecules of human suppressor/cytotoxic cells. Cell 54 (1988) 413-421
28. Bushkin Y., et al. Physical association between the CD8 and HLA class I molecules on the surface of activated human T lymphocytes. Proc. Natl. Acad. Sci. U. S. A. 85 (1988) 3985-3989
29. Auphan N., et al. Biochemical and functional association between CD8 and H-2 at the surface of a T cell clone. Mol. Immunol. 28 (1991) 827-837
30. d to CD8: interaction with the amino terminus of a mature cell surface protein. J. Immunol. 160 (1998) 2809-2814
31. 2m heterodimer. Nat. Struct. Biol. 5 (1998) 377-384
32. Zacharias M., and Springer S. Conformational flexibility of the MHC class I α1-α2 domain in peptide bound and free states: a molecular dynamics simulation study. Biophys. J. 87 (2004) 2203-2214
33. Bennett M.J., et al. Crystal structure of the hereditary hemochromatosis protein HFE complexed with transferrin receptor. Nature 403 (2000) 46-53
34. Olson R., et al. Structure of a pheromone receptor-associated MHC molecule with an open and empty groove. PLoS Biol. 3 (2005) e257. http://biology.plosjournals.org 10.1371/journal.pbio.0030257
35. Lebrón J.A., and Bjorkman P.J. The transferrin receptor binding site on HFE, the class I MHC-related protein mutated in hereditary hemochromatosis. J. Mol. Biol. 289 (1999) 1109-1118
36. Olson R., et al. MHC homologs in the nervous system - they haven't lost their groove. Curr. Opin. Neurobiol. 16 (2005) 351-357
37. Mitra A.K., et al. Supine orientation of a murine MHC class I molecule on the membrane bilayer. Curr. Biol. 14 (2004) 718-724
38. 2-microglobulin on functional recognition of H-2Kb by the NK cell inhibitory receptor Ly49C. J. Immunol. 175 (2005) 3542-3553
39. 2-microglobulin-free HLA-G molecules. J. Immunol. 175 (2005) 4866-4874
40. Capps G.G., et al. In vivo dimeric association of class I MHC heavy chains. Possible relationship to class I MHC heavy chain-beta 2-microglobulin dissociation. J. Immunol. 151 (1993) 159-169
41. Chakrabarti A., et al. Self-association of class I major histocompatibility complex molecules in liposome and cell surface membranes. Biochemistry 31 (1991) 7182-7189
42. Matko J., et al. Clustering of class I HLA molecules on the surfaces of activated and transformed human cells. J. Immunol. 152 (1994) 3353-3360
43. Jenei A., et al. HLA class I and II antigens are partially co-clustered in the plasma membrane of human lymphoblastoid cells. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 7269-7274
44. Triantafilou K., et al. Human major histocompatibility molecules have the intrinsic ability to form homotypic associations. Hum. Immunol. 61 (2000) 585-598
45. Dangoria N.S., et al. HLA-B27 misfolding is associated with aberrant intermolecular disulfide bond formation (dimerization) in the endoplasmic reticulum. J. Biol. Chem. 277 (2002) 23459-23468
46. Boyson J.E., et al. Disulfide bond-mediated dimerization of HLA-G on the cell surface. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 16180-16185
47. Bird L.A., et al. Lymphoblastoid cells express HLA-B27 homodimers both intracellularly and at the cell surface following endosomal recycling. Eur. J. Immunol. 33 (2003) 748-759
48. Antoniou A.N., et al. Formation of HLA-B27 homodimers and their relationship to assembly kinetics. J. Biol. Chem. 279 (2004) 8895-8902
49. 2-microglobulin: implications in activation of cytotoxic T lymphocytes. Int. Immunol. 15 (2003) 331-339
50. Carreno B.M., and Hansen T.H. Exogenous peptide ligand influences the expression and half-life of free HLA class I heavy chains ubiquitously detected at the cell surface. Eur. J. Immunol. 24 (1994) 1285-1292
51. Edidin M., et al. Probing the stability of class I major histocompatibility complex (MHC) molecules on the surface of human cells. Immunogenetics 46 (1997) 41-45
52. 2-microglobulin-free HLA class I α-chains on activated T cells requires internalization of HLA class I heterodimers. Immunology 88 (1996) 104-109
53. Santos S.G., et al. Lack of tyrosine 320 impairs spontaneous endocytosis and enhances release of HLA-B27 molecules. J. Immunol. 176 (2006) 2942-2949
54. 2-microglobulin free HLA class I α-chains. Qualitative and quantitative characterization. J. Immunol. 151 (1993) 2613-2622
55. Dong Y., et al. Soluble nonclassical HLA generated by the metalloproteinase pathway. Hum. Immunol. 64 (2003) 802-810
56. Poggi A., and Zocchi M.R. Cyclosporin A regulates human NK cell apoptosis induced by soluble HLA-I or by target cells. Autoimmun. Rev. 4 (2005) 532-536
57. Machy P., et al. Major histocompatibility complex class I molecules internalized via coated pits in T lymphocytes. Nature 328 (1987) 724-726
58. Dasgupta, et al. Receptor-like nature of class I HLA: endocytosis via coated pits. J. Immunol. 141 (1988) 2577-2580
59. 2-microglobulin. J. Immunol. 146 (1991) 1862-1867
60. Vega M.A., and Strominger J.L. Constitutive endocytosis of HLA class I antigens requires a specific portion of the intracytoplasmic tail that shares structural features with other endocytosed molecules. Proc. Natl. Acad. Sci. U. S. A. 86 (1998) 2688-2692
61. Bonifacino J.S., and Traub L.M. Signals for sorting of transmembrane proteins to endosomes and lysosomes. Annu. Rev. Biochem. 72 (2003) 395-447
62. Lizee G., et al. Tails of wonder: endocytic-sorting motifs key for exogenous antigen presentation. Trends Immunol. 26 (2005) 141-149
63. Benichou S., and Benmerah A. The HIV nef and the Kaposi-sarcoma-associated virus K3/K5 proteins: 'parasites' of the endocytosis pathway. Med. Sci. (Paris) 19 (2003) 100-106
64. 2-microglobulin-associated, and a free, nonphosphorylated, chain of MHC class I. J. Immunol. 151 (1993) 211-224
65. 2-microglobulin from HLA class I heavy chains correlates with acquisition of epitopes in the cytoplasmic tail. J. Immunol. 154 (1995) 5205-5215
66. Casabo L.G., et al. T cell activation results in physical modification of the mouse CD8 beta chain. J. Immunol. 152 (1994) 397-404
67. Florke R.R., et al. Hormone-triggered conformational changes within the insulin-receptor ectodomain: requirement for transmembrane anchors. Biochem. J. 360 (2001) 189-198
68. Matyus L., et al. Distinct association of transferrin receptor with HLA class I molecules on HUT-102B and JY cells. Immunol. Lett. 44 (1995) 203-208
69. Vamosi G., et al. IL-2 and IL-15 receptor α-subunits are co-expressed in a supramolecular receptor cluster in lipid rafts of T cells. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 11082-11087
70. Svejgaard A., and Ryder L.P. Interaction of HLA molecules with non-immunological ligands as an explanation of HLA and disease associations. Lancet 2 (1976) 547-549
71. Stagsted J., et al. Regulation of insulin receptor functions by a peptide derived from a major histocompatibility complex class I antigen. Cell 62 (1990) 297-307
72. Stagsted J. Journey beyond immunology. Regulation of receptor internalization by major histocompatibility complex class I (MHC-I) and effect of peptides derived from MHC-I. APMIS Suppl. 85 (1998) 1-40
73. Pedersen A.E., et al. Signal transduction by the major histocompatibility complex class I molecule. APMIS Suppl. 107 (1999) 887-895
74. Doucey M.A., et al. Cis association of Ly49A with MHC class I restricts natural killer cell inhibition. Nat. Immunol. 5 (2004) 328-336
75. Dubois M.J., et al. The SHP-1 protein tyrosine phosphatase negatively modulates glucose homeostasis. Nat. Med. 12 (2006) 549-556
76. Najjar S.M. Regulation of insulin action by CEACAM1. Trends Endocrinol. Metab. 13 (2002) 240-245
77. Azuz-Lieberman, et al. The involvement of NK cells in ankylosing spondylitis. Int. Immunol. 17 (2005) 837-845
78. Fishman D., et al. Non-immune functions of MHC class I glycoproteins in normal and malignant cells. (Folia Biol.) Praha 50 (2004) 35-42
79. Vamosi G., et al. The role of supramolecular protein complexes and membrane potential in transmembrane signaling processes of lymphocytes. Immunol. Lett. 104 (2006) 53-58
80. Fooksman D.R., et al. Clustering class I MHC modulates sensitivity of T cell recognition. J. Immunol. 176 (2006) 6673-6680
81. Shiroishi M., et al. Efficient leukocyte Ig-like receptor signaling and crystal structure of disulfide-linked HLA-G dimers. J. Biol. Chem. 281 (2006) 10439-10447
82. Allen R.L., and Trowsdale J. Recognition of classical and heavy chain forms of HLA-B27 by leukocyte receptors. Curr. Mol. Med. 4 (2004) 59-65
83. Raine T., and Allen R. MHC-I recognition by receptors on myelomonocytic cells: new tricks for old dogs?. Bioessays 27 (2005) 542-550
84. + T cells. Curr. Mol. Med. 4 (2004) 51-58
85. Colbert R.A. The immunobiology of HLA-B27: variations on a theme. Curr. Mol. Med. 4 (2004) 21-30
86. Cauli A., et al. Increased level of HLA-B27 expression in ankylosing spondylitis patients compared with healthy HLA-B27-positive subjects: a possible further susceptibility factor for the development of disease. Rheumatology 41 (2002) 1375-1379
87. Raine T., et al. Consistent patterns of expression of HLA class I free heavy chains in healthy individuals and raised expression in spondyloarthropathy patients point to physiological and pathological roles. Rheumatology 45 (2006) 1338-1344
88. Solano A.R., et al. Molecular and biological interaction between major histocompatibility complex class I antigens and luteinizing hormone receptors or β-adrenergic receptors triggers cellular response in mice. Proc. Natl. Acad. Sci. U. S. A. 85 (1988) 5087-5091
89. Neuman, et al. The action of luteinizing hormone on the testis. J. Steroid Biochem. Mol. Biol. 40 (1991) 441-451
90. 2-microglobulin chain of HLA complex. Science 224 (1984) 509-511
91. Amiot M., et al. HLA class I molecules are associated with CD1a heavy chains on normal human thymus cells. Proc. Natl. Acad. Sci. U. S. A. 85 (1988) 4451-4454
92. Bushkin Y., et al. A new HLA-linked T cell membrane molecule, related to the beta chain of the clonotypic receptor, is associated with T3. J. Exp. Med. 164 (1986) 458-473
93. Bene L., et al. Lateral organization of the ICAM-1 molecule at the surface of human lymphoblasts: a possible model for its co-distribution with the IL-2 receptor, class I and class II HLA molecules. Eur. J. Immunol. 24 (1994) 2115-2123
94. Bene L., et al. Membrane topography of HLA I, HLA II, and ICAM-1 is affected by IFN-γ in lipid rafts of uveal melanomas. Biochem. Biophys. Res. Commun. 322 (2004) 678-683
95. 2-microglobulin complexes. J. Immunol. 158 (1997) 2790-2797
96. sα-MHC I complexes after desensitization of human platelets with iloprost. Eur. J. Biochem. 259 (1999) 167-174
97. Claas F.H., et al. The interaction between gamma-type endorphins and HLA class I antigens. Hum. Immunol. 15 (1986) 347-356
98. Mommaas A.M., et al. Internalization of MHC class I molecules is a prerequisite for endocytosis of endorphin by lymphocytes. Clin. Exp. Immunol. 84 (1991) 170-174